You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

with a KRAS G12C mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Santa Rosa, California
    Providence Medical Foundation
May 2, 2023

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Adelaide, South Australia, Australia
    Cancer Research SA
Aug 15, 2022

Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with

Recruiting
  • Advanced NSCLC
  • Metastatic Lung Cancer
  • Adagrasib in combination with pembrolizumab
  • Pembrolizumab
  • East Syracuse, New York
  • +2 more
Nov 28, 2022

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (JDQ443, trametinib, Ribociclib)

Recruiting
  • KRAS G12C Mutant Solid Tumors
  • +10 more
  • Boston, Massachusetts
  • +5 more
Jan 11, 2023

NSCLC Trial in Busan (GDC-6036, Pembrolizumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Busan, Korea, Republic of
    Pusan National University Hospital
Apr 3, 2023

Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer Trial in Santa Monica, Plantation (HBI-2438)

Not yet recruiting
  • Lung Cancer
  • +6 more
  • Santa Monica, California
  • +1 more
Aug 2, 2022

Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Jilin, Changchun, China
    Jilin Province Cancer Hospital
Aug 15, 2022

Advanced Solid Tumor Trial (YL-15293)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Dec 14, 2021

Advanced Cancer, Metastatic Cancer, Malignant Tumor Trial in Santa Rosa (adagrasib (MRTX849))

Available
  • Advanced Cancer
  • +2 more
  • adagrasib (MRTX849)
  • Santa Rosa, California
    Providence Medical Group Santa Rosa - Cancer Center
Jan 19, 2022

Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

Recruiting
  • Advanced Solid Tumor
  • Houston, Texas
  • +1 more
Feb 18, 2022

Colo-rectal Cancer Trial in Manchester (therascreen® KRAS RGQ PCR Kit)

Recruiting
  • Colo-rectal Cancer
  • therascreen® KRAS RGQ PCR Kit
  • Manchester, United Kingdom
    QIAGEN Gaithersburg, Inc
Apr 20, 2022

Advanced Solid Tumor Trial in Whittier, New York, Houston (YL-15293)

Recruiting
  • Advanced Solid Tumor
  • Whittier, California
  • +2 more
Nov 11, 2021

Advanced Solid Tumor, NSCLC, CRC Trial in United States (JAB-21822 (KRAS G12C inhibitor), Cetuximab (EGFR inhibitor))

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • JAB-21822 (KRAS G12C inhibitor)
  • Cetuximab (EGFR inhibitor)
  • Phoenix, Arizona
  • +3 more
Sep 7, 2021

Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

Recruiting
  • Advanced Solid Tumors
  • GEC255 tablets
  • Chengdu, Sichuan, China
    China West Hospital
Mar 14, 2023

Advanced Colorectal Cancer, Small Intestinal Cancer, Appendiceal Cancer Trial in China (JAB-21822, Cetuximab)

Recruiting
  • Advanced Colorectal Cancer
  • +2 more
  • Beijing, Beijing, China
  • +11 more
Mar 22, 2022

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)

Active, not recruiting
  • Advanced Cancer
  • +4 more
  • Saint Louis, Missouri
  • +3 more
Apr 4, 2022

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

Recruiting
  • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
  • Montpellier, France
  • +7 more
Dec 19, 2022

Advanced Solid Tumor, NSCLC, Colorectal Cancer Trial in Australia, United States (LY3499446, Abemaciclib, Cetuximab)

Terminated
Has Results
  • Advanced Solid Tumor
  • +2 more
  • Indianapolis, Indiana
  • +5 more
Oct 27, 2021